Last reviewed · How we verify
NCT06645301
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
EARLY_PHASE1 trial testing Group A in Colorectal Cancer in 15 participants. Not yet recruiting.
31 August 2026
Quick facts
| Lead sponsor | BioSyngen Pte Ltd |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 30 November 2024 |
| Primary completion | 31 August 2026 |
| Estimated completion | 31 August 2027 |
Drugs / interventions tested
- Group A
- Group B
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
- Pancreatic Cancer — all drugs for Pancreatic Cancer →
Sponsor
BioSyngen Pte Ltd — full company profile →
Who can join
Adults 17 to 75, any sex, with Colorectal Cancer or Pancreatic Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is an exploratory research on single arm, open, and improved "3+3" dose escalation. BGT007 will explore two dose groups, namely (Group A: 3.0X10 \^ 8 3 cases, Group B: 6.0X10 \^ 8 3 cases), and receive the same dose infusion after observing lower adverse reactions and initial benefits (SD or PR), with an interval of one month. Each subject can receive a maximum of 3 infusions in total.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06645301
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Group A
Trials testing the same drug.
- NCT07395154 — Comparison of Integrated Neuromuscular Inhibition Technique (INIT) and Active Release Technique (ART) in Patients With U · NA · not yet recruiting
- NCT05765058 — The Efficacy of Tooth Mouse, SFD and NaF in Caries Activity in Root Caries. A Randomized Clinical Trial · NA · not yet recruiting
- NCT07394179 — Transforming Channel Osteotomy Into Tunnel Osteotomy in Zygomatic Implant Preparation · NA · not yet recruiting
- NCT07324174 — A Randomized Controlled Trial on the Effectiveness of Early Versus Conservative Rehabilitation Following Rotator Cuff Re · NA · not yet recruiting
- NCT07504016 — Development of a Novel Cookie Formulation and Evaluation of Its Effects on Glycemic Control in Healthy Individuals · NA · completed
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Other BioSyngen Pte Ltd trials
Trials by the same sponsor.
- NCT06645314 — Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma · EARLY_PHASE1 · not yet recruiting
- NCT06643910 — A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer · NA · not yet recruiting
- NCT06526832 — A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer · Phase 1 · unknown
- NCT06173726 — Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection i · EARLY_PHASE1 · not yet recruiting
- NCT06152757 — BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06645301 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BioSyngen Pte Ltd
- Last refreshed: 16 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06645301.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing